Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

C-REACTIVE PROTEIN - ANVISA Registration 10287411736

Access comprehensive regulatory information for C-REACTIVE PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411736 and manufactured by LUMIRADX UK LTD. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including Nanosens Ltda, LABTEST DIAGNOSTICA S/A, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10287411736
Registration Details
ANVISA Registration Number: 10287411736
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

LumiraDx CRP Test
Risk Class II

Registration Details

10287411736

25351015781202544

30280358000186

Company Information

LUMIRADX UK LTD
United Kingdom
PT: REINO UNIDO

Dates and Status

Mar 05, 2025

VIGENTE

09/18/2025 19:00:01